Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Cyabra, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Cyabra, Inc.’s 10-Q, filed May 15, 2026.
- Filed
- May 15, 2026, 4:26 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-057819
| Line item | For the three months ended March 31, 2026 | For the three months ended March 31, 2025 |
|---|---|---|
| Cost of revenues | 192 | 196 |
| Gross profit | 1,223 | 1,064 |
| Operating costs and expenses | ||
| Research and development expenses | 5,508 | 1,851 |
| Sales and marketing expenses | 1,255 | 1,736 |
| General and administrative expenses | 6,284 | 1,515 |
| Total operating loss | (11,824) | (4,038) |
| Finance income | 1,054 | 724 |
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Cyabra, Inc.'s R&D?
- Cyabra, Inc. (CYAB) reported R&D of $5.51M in Q1 2026.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Cyabra, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude